Michaela Hagenhofer, General Manager, Commercial Operations at Johnson & Johnson Innovative Medicine, explains how J&J is ...

Johnson & Johnson eyes FDA nod to icotrokinra after phase III studies show strong skin clearance and safety in plaque ...

Bio-Thera Solutions, Ltd (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative ...

AbbVie remains strong long-term performer, offering a solid dividend yield and robust revenue growth despite share price dips. Click to read why ABBV is a Hold.

Icotrokinra was jointly discovered and is being developed pursuant to the license and collaboration agreement between ...

The Motley Fool. DATE Wednesday, July 16, 2025 at 8:30 a.m. ET CALL PARTICIPANTS Chairman and Chief Executive Officer — ...

While Stelara is used in fewer indications than Humira, it commands a large market share in its therapeutic areas, most ...

Ulcerative colitis (UC) causes misery for millions worldwide. It affects the large intestine, causing pain, cramping, and ...

Individuals with ulcerative colitis have an increased risk for certain types of cancer based on age, instead of treatment type.

Greater access to innovative treatments could be linked to a drop in patients requiring surgery for a type of inflammatory ...